In June 2017 the Irish Platform for Patients Organisations, Science and Industry (IPPOSI) and the Medical Research Charities Group (MRCG) co-hosted a meeting for patient organisations on the issue of Access to Medicines in Ireland. A Consensus Report arising from this meeting has now been published.
MS Ireland participated in the meeting and provided case studies on Fampyra, Sativex and the campaign for centralised funding for Tysabri and Lemtrada.
You can read the report here